INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
GP

Gerber Hans-Peter

CHIEF SCIENTIFIC OFFICERCIK 0001992979

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score17
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
GP
Gerber Hans-PeterCHIEF SCIENTIFIC OFFICER
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
3,750 sh
Sep 18, 2026Sep 22, 2026
traded Sep 18, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SUTRO BIOPHARMA, INC.CHIEF SCIENTIFIC OFFICER · Dec 29, 2025
13
GP
Gerber Hans-PeterCHIEF SCIENTIFIC OFFICER
STROSUTRO BIOPHARMA, INC.
Tax withholding
F
$21K
1,345 sh
Sep 18, 2026
Sep 22, 2026
traded Sep 18, 2026
+4d
SEC FORM 4

Evidence

9
GP
Gerber Hans-PeterCHIEF SCIENTIFIC OFFICER
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
3,750 sh
Sep 18, 2026Sep 22, 2026
traded Sep 18, 2026
+4dSEC FORM 4

Evidence

15
GP
Gerber Hans-PeterCHIEF SCIENTIFIC OFFICER
STROSUTRO BIOPHARMA, INC.
Grant or award
A—
7,925 sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC FORM 4

Evidence